Meningococcal serogroup A and tetanus immunity two years after MenAfriVac™ introduction in Mali
Main Authors: | N.E. Basta, S. Ng, A. Berthe, X. Bai, H. Findlow, R. Almond, R. Borrow, S. Sow |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2014-04-01
|
Series: | International Journal of Infectious Diseases |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1201971214013769 |
Similar Items
-
Effects of MenAfriVac® Introduction in the African Meningitis Belt, 2010-2017
by: Bita Fouda, Andre Arsene
Published: (2018) -
Effects of MenAfriVac(RTM) Introduction in the African Meningitis Belt, 2010--2017
by: Bita Fouda, Andre Arsene
Published: (2019) -
Prevalence and epidemiology of meningococcal carriage in Southern Ethiopia prior to implementation of MenAfriVac, a conjugate vaccine
by: Guro K. Bårnes, et al.
Published: (2016-11-01) -
Understanding the Role of Duration of Vaccine Protection with MenAfriVac: Simulating Alternative Vaccination Strategies
by: Andromachi Karachaliou Prasinou, et al.
Published: (2021-02-01) -
Bacterial meningitis epidemiology and return of Neisseria meningitidis serogroup A cases in Burkina Faso in the five years following MenAfriVac mass vaccination campaign.
by: Alpha Oumar Diallo, et al.
Published: (2017-01-01)